These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11899614)

  • 21. Solid form screening--a review.
    Aaltonen J; Allesø M; Mirza S; Koradia V; Gordon KC; Rantanen J
    Eur J Pharm Biopharm; 2009 Jan; 71(1):23-37. PubMed ID: 18715549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving drug manufacturing with process analytical technology.
    Rodrigues LO; Alves TP; Cardoso JP; Menezes JC
    IDrugs; 2006 Jan; 9(1):44-8. PubMed ID: 16374733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategic use of preparative chiral chromatography for the synthesis of a preclinical pharmaceutical candidate.
    Leonard WR; Henderson DW; Miller RA; Spencer GA; Sudah OS; Biba M; Welch CJ
    Chirality; 2007 Sep; 19(9):693-700. PubMed ID: 17354260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of chiral building blocks for use in drug discovery.
    Marino ST; Stachurska-Buczek D; Huggins DA; Krywult BM; Sheehan CS; Nguyen T; Choi N; Parsons JG; Griffiths PG; James IW; Bray AM; White JM; Boyce RS
    Molecules; 2004 May; 9(6):405-26. PubMed ID: 18007441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymmetric hydrogenation, transfer hydrogenation and hydrosilylation of ketones catalyzed by iron complexes.
    Morris RH
    Chem Soc Rev; 2009 Aug; 38(8):2282-91. PubMed ID: 19623350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
    Aaltonen J; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2008 Dec; 364(2):159-69. PubMed ID: 18555625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-supported chiral catalysts for heterogeneous enantioselective reactions.
    Ding K; Wang Z; Wang X; Liang Y; Wang X
    Chemistry; 2006 Jul; 12(20):5188-97. PubMed ID: 16568490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Applications of asymmetric organocatalysis in medicinal chemistry.
    Alemán J; Cabrera S
    Chem Soc Rev; 2013 Jan; 42(2):774-93. PubMed ID: 23154582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Evolution of Chemical High-Throughput Experimentation To Address Challenging Problems in Pharmaceutical Synthesis.
    Krska SW; DiRocco DA; Dreher SD; Shevlin M
    Acc Chem Res; 2017 Dec; 50(12):2976-2985. PubMed ID: 29172435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
    Zhang ZY; Li HL; Lei ZJ
    Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1933-6. PubMed ID: 17348181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension.
    De Beer TR; Baeyens WR; Ouyang J; Vervaet C; Remon JP
    Analyst; 2006 Oct; 131(10):1137-44. PubMed ID: 17003862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetric hydrogenation of pharmaceutically interesting substrates.
    Lennon IC; Moran PH
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):855-75. PubMed ID: 14758757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts.
    Skibsted ET; Boelens HF; Westerhuis JA; Witte DT; Smilde AK
    J Pharm Biomed Anal; 2006 Apr; 41(1):26-35. PubMed ID: 16289623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation processes for organic molecules using SCF Technologies.
    Daintree LS; Kordikowski A; York P
    Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.